Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Non-Current Liabilities (2020 - 2025)

Rockwell Medical's Total Non-Current Liabilities history spans 11 years, with the latest figure at $20.2 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 21.3% year-over-year to $20.2 million; the TTM value through Dec 2025 reached $20.2 million, down 21.3%, while the annual FY2025 figure was $20.2 million, 21.3% down from the prior year.
  • Total Non-Current Liabilities reached $20.2 million in Q4 2025 per RMTI's latest filing, down from $20.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $46.0 million in Q4 2021 to a low of $19.5 million in Q1 2025.
  • Average Total Non-Current Liabilities over 5 years is $29.7 million, with a median of $28.4 million recorded in 2023.
  • Peak YoY movement for Total Non-Current Liabilities: grew 7.7% in 2024, then crashed 35.01% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $46.0 million in 2021, then decreased by 29.35% to $32.5 million in 2022, then decreased by 12.71% to $28.4 million in 2023, then dropped by 9.72% to $25.6 million in 2024, then fell by 21.3% to $20.2 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Total Non-Current Liabilities are $20.2 million (Q4 2025), $20.5 million (Q3 2025), and $22.2 million (Q2 2025).